Viking Global Investors Lp - Significant Ownership

Signature - Title
/s/ Scott M. Hendler - Scott M. Hendler on behalf of VIKING GLOBAL INVESTORS LP (1)(2)(3)
Location
Stamford, CT
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Viking Global Investors Lp.

Significant Ownership of Viking Global Investors Lp

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CZOOF Cazoo Group Ltd Class A Ordinary Shares, par value $0.20 per share 43.8% $42.9K 2.14M VIKING GLOBAL INVESTORS LP Feb 1, 2024
ACUREN CORP Common Stock, par value $0.0001 per share 28.3% 34.4M VIKING GLOBAL INVESTORS LP Mar 31, 2025
ORIC Oric Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share 9.99% $89.6M $22.1M 8.73M +32.8% VIKING GLOBAL INVESTORS LP Jun 30, 2025
BBIO BridgeBio Pharma, Inc. Common Stock, par value $0.001 per share 8.2% $826M -$141M 15.9M -14.6% VIKING GLOBAL INVESTORS LP Nov 14, 2025
SION Sionna Therapeutics, Inc. Common Stock, $0.001 par value per share 6.7% $22.6M 2.95M VIKING GLOBAL INVESTORS LP Feb 10, 2025
NAMS NewAmsterdam Pharma Co N.V. Ordinary Shares, nominal value EUR0.12 per share 6.5% $106M 6.98M VIKING GLOBAL INVESTORS LP Dec 31, 2024
FTV Fortive Corp Common Stock, par value $0.01 per share 6.4% $1B $168M 20.5M +20.1% VIKING GLOBAL INVESTORS LP Sep 30, 2025
ORKA Oruka Therapeutics, Inc. Common Stock, $0.001 par value per share 5.5% $38.7M 2.67M VIKING GLOBAL INVESTORS LP Sep 17, 2025
PRMB Primo Brands Corp Class A common stock, $0.01 par value per share 5.3% $626M 19.6M VIKING GLOBAL INVESTORS LP Jun 11, 2025
PEPG PepGen Inc. Common Stock, par value $0.0001 per share 5.1% $4.18M 3.48M VIKING GLOBAL INVESTORS LP Sep 26, 2025
SAIA SAIA INC Common Stock, par value $0.001 per share 5.02% $392M 1.34M VIKING GLOBAL INVESTORS LP Sep 3, 2025
RRX REGAL REXNORD CORP Common Stock, $0.01 par value per share 4.7% $448M -$44M 3.12M -8.95% VIKING GLOBAL INVESTORS LP Sep 30, 2025
BMRN BIOMARIN PHARMACEUTICAL INC Common Stock, par value $0.001 per share 4.3% $451M -$215M 8.32M -32.3% VIKING GLOBAL INVESTORS LP Sep 30, 2025
TRVI Trevi Therapeutics, Inc. Common Stock, $0.001 par value per share 4.2% $46.9M -$21.7M 5.13M -31.7% VIKING GLOBAL INVESTORS LP Sep 30, 2025
ROIV Roivant Sciences Ltd. Common Shares, $0.0000000341740141 par value per share 3.4% $357M -$161M 23.6M -31.1% VIKING GLOBAL INVESTORS LP Sep 30, 2025
APG APi Group Corp Common Stock, $0.0001 par value per share 2.8% $414M -$358M 11.5M -46.4% VIKING GLOBAL INVESTORS LP Jun 30, 2025
LBPH Longboard Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 0% $0 0 VIKING GLOBAL INVESTORS LP Dec 31, 2024

Schedules 13D/G Reported by Viking Global Investors Lp:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.